Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Using setbacks as stepping stones in Alzheimer’s research

By Gretta Stone  |    August 3, 2016
For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for...   Read More

Biopharmaceutical industry is essential to development of Alzheimer’s treatments

By Holly Campbell  |    December 23, 2015
This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a better...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    July 17, 2015
Neurological Disorders: America’s biopharmaceutical companies are committed to developing innovative new treatments for the nearly 50 million Americans affected by neurological disorders. This...   Read More

In Case You Missed It: Progress and Promise in Alzheimer’s Research

By Tina Stow  |    July 15, 2015
PhRMA recently convened a panel of health care experts for a live webcast discussion about the current state of research to treat and care for Alzheimer’s disease. Dr. Bill Chin of PhRMA moderated...   Read More

The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

By Bill Chin, M.D.  |    July 15, 2015
Alzheimer’s disease steals memories, relationships and independence. It is a ruthless, devastating disease ravaging more than 5 million people in the United States alone, and is the sixth-leading...   Read More

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

By Tina Stow  |    July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    July 10, 2015
Healthy Outlook: The Cancer Support Community’s Rob Goldsmith highlighted a new report from his organization that found discrepancies in the definition of value in cancer care. July 15 Webcast...   Read More

PhRMA Webcast to Examine Progress and Promise of Alzheimer’s Research

By Tina Stow  |    July 9, 2015
Alzheimer’s disease has a devastating impact on patients, their loved ones and the caregivers who help them navigate their daily lives. It’s a particularly cruel disease – one that is especially...   Read More

New Video: How Medicines Can Curb Health Care Costs

By Holly Campbell  |    June 2, 2015
Hospital visits, surgeries and long-term care place a heavy burden on our nation’s health care system, and the weight is only projected to increase. In just the next decade, the U.S. will spend...   Read More

Week in Review: Commitment to Patient Well-Being

By Christian Clymer  |    January 30, 2015
For the biopharmaceutical industry, patient well-being is at the center of everything we do. In keeping patients at the forefront, we are doing all that we can to help people live longer,...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

Subscribe to Email Updates